ADAPTIMMUNE THERAPEUTICS PLC Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $0 as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2024-11-13
- 2024-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $0.00.
- 2024-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $0.00.
- 2023-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $1.00K.
- 2023-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $13.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-12 |
| 2023-12-31 | $1.00K 10-Q · filed 2024-11-13 |
| 2023-09-30 | $13.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $136.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $458.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $930.00K 10-Q · filed 2023-11-08 |
| 2022-06-30 | $1.83M 10-Q · filed 2022-08-04 |
| 2021-12-31 | $390.00K 10-Q · filed 2022-08-04 |